CellWell record HH-19391
Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study
Zhu X; Lin X; Zhang P; Liu Y; Ling W; Guo H
Clinics and research in hepatology and gastroenterology ยท 2022
In plain language
In NAFLD patients, a 12-week randomized trial found 320 mg/day anthocyanins was associated with markedly reduced NLRP3 inflammasome activity, lowering the inflammatory signals IL-1 beta and IL-18 that are elevated in fatty liver.
- Evidence
- Established
- Design
- Randomized controlled trial
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-19391
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.